Paxlovid mushonga wekuferefeta unoshandiswa kurapa zvinyoro-kusvika-zvine mwero COVID-19 muvakuru nevana [makore gumi nemaviri ekuberekwa zvichikwira anorema makirogiramu makumi masere nemasere (40 kg) nemhedzisiro yakanaka yekunanga SARS-CoV-2 hutachiona kuongororwa, uye vari panjodzi huru yekufambira mberi kune yakanyanya COVID-19, kusanganisira kuchipatara kana kufa. Paxlovid ndeyekuferefeta nekuti ichiri kudzidzwa. Pane ruzivo rushoma nezve kuchengetedzeka uye kushanda kwekushandisa Paxlovid kurapa vanhu vane hunyoro-ku-pakati-kati COVID-19.
Iyo FDA yakabvumidza kushandiswa kwechimbichimbi kwePaxlovid kurapwa kwehunyoro-kusvika-pakati COVID-19 muvakuru nevana [makore gumi nemaviri ekuberekwa zvichikwira vanorema makirogiramu makumi masere nemasere (40 kg) nekuongororwa hutachiona. inokonzeresa COVID-19, uye vari panjodzi huru yekufambira mberi kune yakanyanya COVID-19, kusanganisira kuchipatara kana kufa, pasi peEUA.

Paxlovid hausi mushonga unotenderwa neFDA muUnited States. Taura nemutarisiri wako wehutano nezvezvaungasarudza kana uine mibvunzo. Isarudzo yako kutora Paxlovid.

Paxlovid ine mishonga miviri: nirmatrelvir uye ritonavir.

Nirmatrelvir [PF-07321332] is a SARS-CoV-2 main protease (Mpro) inhibitor (inozivikanwawo seSARS-CoV2 3CL protease inhibitor) inoshanda nekudzivisa kudzokororwa kwehutachiona mumatanho ekutanga echirwere kudzivirira kufambira mberi kune yakanyanya COVID- 19.

Ritonavir inopihwa pamwe chete nenirmatrelvir kubatsira kunonotsa metabolism yayo kuitira kuti irambe ichishanda mumuviri kwenguva yakareba panguva yakakwira kubatsira kurwisa hutachiona.